- XV Eurasian Hematology-Oncology Congress - EHOC 2024
- XIV Eurasian Hematology-Oncology Congress - EHOC 2023
- 8th Eurasian Hematology Oncology Summit
- XIth Eurasian Hematology-Oncology Congress - EHOC 2020
- 7th Eurasian Hematology Oncology Summit
- Xth Eurasian Hematology-Oncology Congress
- Events
Playback speed
10 seconds
Systemic Adjuvant Therapy in Early HER2+ Breast Cancer: Escalating w/New HER2 Targeted Tx (Neratinib, Pertuzumab, T-DMI1), and When to De-Escalate?
By
Xth Eurasian Hematology-Oncology Congress
FEATURING
Cagatay Arslan
By
Xth Eurasian Hematology-Oncology Congress
FEATURING
Cagatay Arslan
0 views
December 4, 2019
Comments 0
Login to view comments.
Click here to Login
Breast